{"id":"NCT01137812","sponsor":"Janssen Research & Development, LLC","briefTitle":"The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)","officialTitle":"A Randomized, Double-Blind, Active-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin Versus Sitagliptin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sulphonylurea Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-07","primaryCompletion":"2012-03","completion":"2012-03","firstPosted":"2010-06-04","resultsPosted":"2013-05-17","lastUpdate":"2015-01-15"},"enrollment":756,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Sitagliptin 100 mg","otherNames":[]},{"type":"DRUG","name":"Canagliflozin 300 mg","otherNames":[]},{"type":"DRUG","name":"Metformin","otherNames":[]},{"type":"DRUG","name":"Sulphonylurea","otherNames":[]}],"arms":[{"label":"Canagliflozin 300 mg","type":"EXPERIMENTAL"},{"label":"Sitagliptin 100 mg","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of canagliflozin compared with sitagliptin in patients with type 2 diabetes mellitus who are receiving treatment with metformin and sulphonylurea and have inadequate glycemic (blood sugar) control.","primaryOutcome":{"measure":"Change in HbA1c From Baseline to Week 52","timeFrame":"Day 1 (Baseline) and Week 52","effectByArm":[{"arm":"Canagliflozin 300 mg","deltaMin":-1.03,"sd":0.048},{"arm":"Sitagliptin 100 mg","deltaMin":-0.66,"sd":0.049}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.05"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":184,"countries":["United States","Austria","Belgium","Brazil","Canada","Denmark","France","Germany","India","Israel","Malaysia","Netherlands","New Zealand","Poland","Singapore","South Korea","Ukraine"]},"refs":{"pmids":["29313267","27977934","27391951","26580237","26579834","25795432","24585202","23564919"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":24,"n":377},"commonTop":["Hypoglycaemia","Nasopharyngitis","Headache","Upper respiratory tract infection","Diarrhoea"]}}